Year: 2004
Type: article
Abstract: We are happy that our recent editorial (1) stimulated interest from other experts in the diabetic foot. However, we find ourselves in disagreement with the letter by Jeffcoate and Game in this issue of Diabetes Care (2) in several respects. They suggest that our editorial betrays “a failure to understand how the structure of trials must be determined.” Surely, this cannot be the case. Any trial assessing dressings, drugs, or constructs should be designed to provide the maximum opportunity for the product to demonstrate efficacy by removing all possible confounding variables. As we have recently …
Source: Diabetes Care
Authors: Andrew J.M. Boulton, David G. Armstrong
Institutions: University of Miami, Southern Arizona VA Health Care System
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Novo Nordisk
OpenAlex ID: W2060252183